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Examination of periods at risk in human life in relation to later
development of malignant disease has recently extended towards
the intrauterine life (Trichopoulos and Lipworth, 1995). However,
the study of the fetal period in people born a long time ago repre-
sents a problem. One way to obtain such information is to examine
birth weight, and several studies have commented upon birth
weight in relation to malignant disease in adult life (Tibblin et al,
1995; Michels et al, 1996; Platz et al, 1998; Ekbom et al, 2000,
Stavola et al, 2000). However, birth weight may also be rather
difficult to obtain of children born early in the 20th century, as the
birth  records very often are lost.
Twins are often born at an earlier gestational age than singletons
and often with a reduced birth weight. A careful study of twins in
Norway in the period 1919–1930 found that pregnancy in twins
was 16 days shorter (mean) compared with singletons (Waaler,
1934).
Since 1967 all the births in Norway are registered in the
Medical Birth Registry of Norway. However, the population in this
registry has not yet reached main age groups for cancer except for
malignant disease among children. Thus, this particular registry is
for the time being of minor importance for examining the relation-
ship between the intrauterine period and later malignant disease.
To study such questions we initiated a large-scale project to iden-
tify twins born in Norway in the period 1905–1945 (The National
Twin Register) and we have taken the opportunity to match this
register against the National Cancer Registry. This has enabled us
to examine cancer risk among twins compared with the general
population.
MATERIALS AND METHODS 
In Norway, local clergymen were for a long time entrusted with
registering all births for Statistics Norway. Until 1916, the returns
to this register were based on the records in the parish registers.
Since then, details of all infants have been entered in the birth
register, which is a civil affair regardless of whether or not
the parents belong to the state church. The twin register was
established covering the period 1895–1945 (Kringlen, 1978). In
Norway the 11-digit personal identity number for every individual
in Norway has been in use since the autumn of 1964, was initially
based on the census of 1960. Thus, we can identify only those
twins who were alive in the period covered by the identity number.
As the authorities did not allow us to contact the twins or their
families, we could not study the zygosity of the twins. 
Among twins born 1905–1945 we were able to identify 23 334
individuals with personal identity numbers in which both members
of the twin pair were alive at the census of 1960 (representing
40% of the twins born in Norway in the period 1905–45).
However, those who died before 1960 were lost and also some
cases in which the female twin changed her family name on
marriage. As our material covers twins born during 1905–1945
who were alive in 1960 with malignant disease diagnosed after
1960, we have lost information on childhood cancer occurring in
children as our youngest twin was 15 years old in 1960. Twins are
evenly distributed through the whole period. For these 23 334, the
Cancer Registry of Norway was used to identify cancer cases
among the twins. 
Since 1952, physicians in Norway have been obliged by law to
report all malignant lesions to the Cancer Registry. The Register
has been evaluated and found to be practically complete for all
solid tumours. A comprehensive evaluation of the Cancer Registry
on 1 October 1970 showed that only 0.9% were not reported.
A pilot study covering 2 counties for 1976 was undertaken in
1979 and found 100% completeness for the first county, but only
88% for the other county. However, another evaluation of this par-
ticular county was for the years 1960, 1975 and 1981 and indicated
100% coverage (Lund, 1981; the Cancer Registry, 1982; Harvei
et al, 1996). The identity number for every individual living in
Norway, combined with routine reports from all departments of
pathology and clinical departments when a malignant disease is
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(Statistics Norway), is of great importance in the completeness of
the register. Thus, cancer registration effectively covers the total
population. 
The personal identity number was used to link the cancer
registry with the twin birth cohort of the period 1905–1945.
Information regarding emigration and death was also collected.
For the analysis of cancer, each person was followed from 1
January 1960 until date of death, emigration, diagnosis of first
malignant tumour or the end of the follow-up on 31st December
1996, whichever came first. Emigration represented less than
0.1%, with no other loss to follow-up. Our analyses are based on a
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Table 1 Standardized incidence rate (SIR) and 95% confidence interval (CI) among 23 334 twins in Norway born 1905–1945 where both of the twins were
identified. (Person years at risk: total 709 009, males 369 418 and females 339 591) 
Cancer site ICD-7 code Observed Expected  SIR CI 
Lip 140 
males 29 22.7 1.28 0.86–1.84 
females 0 2.7 0.0 0.00–1.36 
Oesophagus 150 
males 19 22.2 0.85 0.45–1.74 
females 5 6.3 0.79 0.26–1.85 
Stomach 151 
males 136 129.4 1.05 0.89–1.24 
females 71 70.4 1.01 0.79–1.27 
Colon 153 
males 128 155.43 0.82 0.69–0.98 
females 146 160.4 0.91 0.77–1.07 
Rectum 154 
males 85 102.9 0.83 0.66–1.02 
females 58 75.7 0.77 0.58–0.99 
Pancreas 157 
males 67 63.3 1.06 0.82–1.34 
females 37 48.5 0.76 0.54–1.05 
Larynx 161 
males 28 26.2 1.07 0.71–1.54 
females 2 2.6 0.77 0.09–2.77 
Trachea, bronchus and lung 162 
males 249 263.0 0.95 0.84–1.07 
females 60 79.8 0.75 0.57–0.97 
Breast 170 
males 3 2.7 1.13 0.23–3.30 
females 376 403.0 0.93 0.84–1.03 
Cervix uteri 171 99 104.4 0.95 0.77–1.15 
Corpus uteri 172 100 101.1 0.99 0.81–1.20 
Ovary 175 133 109.9 1.21 1.02–1.43 
Vulva/Vagina 176 22 17.5 1.26 0.79–1.90 
Prostate gland 177 358 339.8 1.05  0.95–1.17 
Testis 178 27 22.6 1.20 0.79–1.74 
Kidney 180 
males 57 72.0 0.79 0.60–1.03 
females 28 39.9 0.70 0.47–1.02 
Bladder 181 
males 135 140.4 0.96 0.81–1.14 
females 32 39.8 0.80 0.55–1.13 
Melanoma of the skin 190 
males 52 70.3 0.74 0.55–0.97 
females 50 68.3 0.73 0.54–0.97 
Other skin 191 
males 53 61.1 0.87 0.65–1.13 
females 41 39.6 1.04 0.74–1.41 
Brain, nervous system 193 
males 52 55.7 0.93 0.70–1.22 
females 34 48.7 0.70 0.48–0.98 
Thyroid gland 194 
males 5 10.3 0.49 0.16–1.13 
females 19 25.4 0.75 0.45–1.17 
Non-solid tumours (200–204) 
males 134 144.2 0.93 0.77–1.09 
females 83 102.9 0.81 0.64–1.00 
All sites 
males 1786 1887.5 0.95 0.90–0.99 
females 1507 1678.4 0.90 0.85–0.94 comparison of the observed number of new cases of cancers in the
cohort during the follow-up period with the expected numbers of
the total population of the country and presented as the standard-
ised incidence ratio (SIR = observed/expected) (Silva dos Santos,
1999). 
RESULTS 
The total person-years of follow-up were 709 009. During the
follow-up period from 1960 to 1996, a total of 3293 cases of
cancer were observed, compared with an expected number of
3566, a reduced risk of malignant disease for all sites combined
(Table 1). The SIR is 0.92 (95% confidence intervals 0.89–0.96). 
With regard to the specific cancer sites, we observed a signifi-
cant reduction of colon cancer in male twins and of rectal cancer in
female twins, and a similar tendency in the opposite gender. In
both sexes, there was a reduced incidence of malignant melanomas
of the skin and non-solid tumours (leukaemia, lymphoma and
myeloma). In females, central nervous system and lung tumours
were reduced with a similar tendency among males and for cancer
of the kidney in both sexes. No cancer showed a significant
increased incidence except cancer of the ovary. 
DISCUSSION 
For some types of cancer, being a twin seems to protect against
malignant disease. A study from Finland covering the period 1976
to 1995 found a slight decrease in the total cancer incidence among
twins (SIR 0.95, 95% CI 0.91–1.00) (Verkasalo et al, 1999). We
have considered the possibility that our observations might be due
to deficient sampling, but we find it unlikely that the reporting
practices for cancer in twins should differ from those in non-twins. 
The reduced incidence of cancer among twins might be the
result of certain shared factors in childhood, such as dietary habits
or other kinds of exposure and not genetic factors. Thus, data from
44 788 pairs of twins from Sweden, Denmark and Finland showed
that inherent genetic factors made a minor contribution to most
types of neoplasm (Lichtenstein et al, 2000), though in testis
cancer a large genetic component together with perhaps nutritional
factors were suggested as causes (Swerdlow et al, 1999). 
There is growing evidence that some types of cancer may origi-
nate in utero; especially in hormone-related cancers (Tibblin et al,
1995; Akre et al, 1996; Ekbom et al, 1996, 1997, 2000; Michels et al,
1996; Ekbom 1998; Cerhan et al, 2000). The reported increased inci-
dence of prostate cancer in the highest quartile of birth weight (Tibblin
et al, 1995) was not confirmed in another study (Platz et al, 1998).
Our data include twins born during 1905–1945 who were alive
in 1960. We have, however, lost information on cancers in children
so we cannot confirm an earlier report showing an increased
number of childhood kidney cancers in twins (Windham et al,
1985). We could not investigate the role of zygosity but we hope to
do this later as have others (Swerdlow et al, 1997). 
We have observed a reduced risk of cancer in twins, and we
consider this a real finding which cannot be explained by deficient
sampling. Twins are often born at an earlier gestation age than
singletons and have a reduced birth weight. In Norway 1919–1930
the mean gestation for twins was 16 days shorter than in singletons,
with a correspondingly lower birth weight (Waaler, 1934). We might
therefore have found the same decreased incidence of malignant
disease in singletons born at a similar early gestation age as the twins. 
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